Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Rexahn Pharmaceuticals, Inc. (RNN)

Rexahn Pharmaceuticals, Inc.
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:RNN
DateTimeSourceHeadlineSymbolCompany
06/11/201922:03Edgar (US Regulatory)Quarterly Report (10-q)AMEX:RNNRexahn Pharmaceuticals, Inc.
06/11/201915:30Edgar (US Regulatory)Unknown (sec Staff)AMEX:RNNRexahn Pharmaceuticals, Inc.
06/11/201915:30Edgar (US Regulatory)Unknown (sec Staff)AMEX:RNNRexahn Pharmaceuticals, Inc.
29/08/201921:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
29/08/201911:46Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/08/201912:02Edgar (US Regulatory)Quarterly Report (10-q)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/08/201911:44Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
10/06/201914:32Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:56Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:41Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201919:20Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
29/05/201917:58Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
28/05/201921:10GlobeNewswire Inc.Rexahn Announces Move to NasdaqAMEX:RNNRexahn Pharmaceuticals, Inc.
13/05/201913:00GlobeNewswire Inc.Rexahn Pharmaceuticals Reports First Quarter 2019 Financial ResultsAMEX:RNNRexahn Pharmaceuticals, Inc.
10/05/201921:22Edgar (US Regulatory)Quarterly Report (10-q)AMEX:RNNRexahn Pharmaceuticals, Inc.
29/04/201921:45Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:RNNRexahn Pharmaceuticals, Inc.
16/04/201913:04Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
16/04/201913:00GlobeNewswire Inc.Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater ChinaAMEX:RNNRexahn Pharmaceuticals, Inc.
12/04/201913:16Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
12/04/201913:00GlobeNewswire Inc.Rexahn Effects 1-for-12 Reverse Stock SplitAMEX:RNNRexahn Pharmaceuticals, Inc.
10/04/201921:07GlobeNewswire Inc.Rexahn Announces Reverse Stock SplitAMEX:RNNRexahn Pharmaceuticals, Inc.
27/03/201912:00GlobeNewswire Inc.Rexahn Announces Multiple Presentations at the 2019 American Association for Cancer Research Annual MeetingAMEX:RNNRexahn Pharmaceuticals, Inc.
26/03/201920:15Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
11/03/201910:55Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
 Showing the most relevant articles for your search:AMEX:RNN